Nonviable tumor tissue should not upstage wilms' tumor from stage I to stage II: A report from the SIOP 93-01 nephroblastoma trial and study

Pediatric and Developmental Pathology

Volumn 12, Issue 2, 2009, Pages 111-115

  Vujanić, Gordan M ^a   Harms, Dieter ^b   Bohoslavsky, Roman ^c   Leuschner, Ivo ^b   De Kraker, Jan ^d   Sandstedt, Bengt ^e  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c Integraal Kankercentrum Amsterdam   (Netherlands)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Nonviable; Prognostic factor; Stage; Viable tumor; Wilms' tumor

Indexed keywords

DACTINOMYCIN; EPIRUBICIN; VINCRISTINE;

ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHILD; EVENT FREE SURVIVAL; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; KIDNEY; KIDNEY NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WILMS TUMOR;

EID: 63449106149     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/08-03-0432.1     Document Type: Article

References (25)

1. Graf N, Tournade M-F, de Kraker J. The role of preoperative chemotherapy in the management of Wilms tumor. Urol Clin N Amer 2000;27:443-154.
2. Neville HL, Ritchey ML. Wilms tumor: overview of National Wilms Tumor Study Group results. Urol Clin North Am 2000;27:435-142.
3. Mitchell C, Jones PM, Kelsey A, et al. The treatment of Wilms tumour: results of the United Kingdom Children's Cancer Study Group [UKCCSG] second Wilms tumour study. Br J Cancer 2000;83: 602-608.
4. Mitchell C, Pritchard Jones K, Shannon R, et al. Immediate nephrectomy versus pre-operative chemotherapy in the management of non-metastatic Wilms tumor: results of a randomized trial (UKWILMS' TUMOUR3) by the UK Children's Cancer Study Group. Eur J Cancer 2006;42:2554-2562.
5. Godzinski J, Tournade M-F, de Kraker J, et al. The role ofpreoperative chemotherapy in the treatment of nephroblastoma: the SIOP experience. Semin Urol Oncol 1999;17:28-32.
6. Godzinski J, Tournade MF, de Kraker J, et al. Rarity of surgical complications after postchemotherapy nephrectomy for nephroblas-toma: experience of the International Society of Pediatric Oncology. Eur J Pediatr Surg 1998;8:83-86.
7. Ritchey ML, Shamberger RC, Haase G, et al. Surgical complications after primary nephrectomy for Wilms tumor: report from the National Wilms Tumor Study Group. J Am Coll Surg 2001;192:63-68.
8. de Kraker J, Graf N, van Tinteren H, et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms tumour (SIOP 93-01 trial): a randomised controlled trail. Lancet 2004;364:1229-1235.
9. Delemarre JFM, Sandstedt B, Harms D, et al. The new SIOP (Stockholm) working classification of renal tumours of childhood. Med Pediatr Oncol 1996;26:145-146.
10. SIOP 93-01 Nephroblastoma Trial and Study Protocol. 1993.
11. Marubini E, Valsecchi MG. Analysing survival data from clinical trials and observational studies. Hoboken, NJ: John Wiley & Sons Ltd, 1995.
12. Weirich A, Leuschner I, Harms D, et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol 2001;12:311-319.
13. Brisigotti M, Cozzutto C, Fabbretti G, Caliendo L. Wilms tumor after treatment. Pediatr Pathol 1992;12:397-406.
14. Guarda LA, Ayala AG, Jaffe N, et al. Chemotherapy-induced histologic changes in Wilms tumors. Pediatr Pathol 1984;2:197-206.
15. Zoeller G, Perkun A, Lakomek M, Ringert R-H. Staging problems in the pre-operative chemotherapy of Wilms tumour. Br J Urol 1995;76: 501-503.
16. Zuppan CW, Beckwith JB, Weeks DA, et al. The effect of preoperative therapy on the histological features of Wilms tumor: an analysis of cases from the third National Wilms Tumor Study. Cancer 1991;68: 385-394.
17. Ritchey ML. The role of preoperative chemotherapy for Wilms tumor: the NWTS perspective. Semin Urol Oncol 1999;17:21-27.
18. Green D. The treatment of stages I-IV favourable histology Wilms tumor. J Clin Oncol 2004;22:1366-1372.
19. Tournade MF, Com-Nouge C, de Kraker J, et al. Results of the Sixth International Society of Pediatric Oncology Wilms Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms tumor. J Clin Oncol 1993;11:1014-1023.
20. Green D. Treatment of Wilms tumor: an international perspective: in reply. J Clin Oncol 2005;23:3157-3158.
21. de Kraker J, Prichard-Jones K. Treatment of Wilms tumor: an international perspective. J Clin Oncol 2005;23:3156-3157.
22. de Kraker J, Delemarre JFM, Lilien MR, Tournade M-F. Mis-staging in nephroblastoma. causes and consequences: a report of the sixth nephroblastoma trial and study of the International Society of Paediatric Oncology. Eur J Pediatr Surg 1999;9:153-157.
23. SIOP 2001 Nephroblastoma Trial and Study Protocol. 2001.
24. Green DM, Cotton CA, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actino-mycyn D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2007;48:493-499.
25. Vujanic GM, Sandstedt B, Harms D, et al. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumours of childhood. Med Pediatr Oncol 2002;38:79-82.